Anti-D administration after childbirth for preventing Rhesus alloimmunisation for subsequent pregnancies

Authors

• Nimisha Kumar, Advocate Health - Midwest
• Morteza A. Khafaie, Environmental Technologies Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
• Shayesteh Jahanfar, Department of Public Health, School of Population and Public Health, University of British Columbia, Vancouver, Canada.
• Anthony L. Shanks, Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Recommended Citation

Kumar N, Khafaie MA, Jahanfar S, Shanks AL. Anti-D administration after childbirth for preventing Rhesus alloimmunisation for subsequent pregnancies. Cochrane Database Syst Rev. 2026;5(5):CD014729. Published 2026 May 5. doi:10.1002/14651858.CD014729

Abstract

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of various doses and timings of anti-D administration for prevention of Rhesus (Rh) alloimmunisation after childbirth in Rh-negative women with an Rh-positive baby.

Document Type

Article

PubMed ID

42084022